Articles by Alexandra U Scherrer, MSc

Viral Suppression Rates in Salvage Treatment With Raltegravir Improved With the Administration of Genotypic Partially Active or Inactive Nucleoside/Tide Reverse Transcriptase...

Scherrer, Alexandra U; Wyl, Viktor von; Böni, Jürg; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1):24-31, May 1, 2011.

Implementation of Raltegravir in Routine Clinical Practice: Selection Criteria for Choosing This Drug, Virologic Response Rates, and Characteristics of Failures

Scherrer, Alexandra U; von Wyl, Viktor; Fux, Christof A; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(4):464-471, April 1, 2010.